Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset
oleh: Stephan Kloess, Alessa Ede Valverde da Silva, Olaf Oberschmidt, Tanja Gardlowski, Nadine Matthies, Maulik Vyas, Lubomir Arseniev, Michael Heuser, Elke Pogge von Strandmann, Ulrike Köhl
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2018-10-01 |
Deskripsi
Subjek
natural killer cells; natural killer group 2 member D; triplebodies; ULBP2; CD19; CD33